ZFTA and cancer: While the present work presents the first epigenomic and transcriptomic characterization of the genetic program induced by the C11orf95-RELA fusion protein, future works on additional ST-EPN-RELA cell lines and primary tumors will further establish the core program as well as subtype differences critical for the development of precision and personalized therapeutics for this devastating cancer.